Navigation Links
TyraTech Achieves Insecticide Development and Financial Milestones With Partner Arysta LifeScience
Date:1/10/2008

MELBOURNE, Fla., Jan. 10 /PRNewswire/ -- TyraTech Inc. (AIM: TYR), the pioneer of safer, effective and natural pesticide products, today announced it has achieved development and financial milestones from Arysta LifeScience Corporation ("Arysta"), as part of its 2006 exclusive global licensing and co-development agreement to manufacture and market a number of insecticide products for certain horticultural markets.

TyraTech is developing proprietary compounds that target receptors found on insects and other invertebrates, but are not found on humans or animals. These compounds -- called TyraTech Naturals -- are derived from plants and can kill insects with the potency of chemical pesticides, but without their toxicity. The partnership with Arysta is to develop new products based on the TyraTech compounds for the control of insects in certain horticultural markets. The partnership has different progressive development stages, which when they are successfully reached, result in milestone payments to TyraTech.

The two milestone payments above relate to achieving specific insecticide efficacy and cost targets for TyraTech Natural products in two of the licensed applications. Field testing for the lead product prototypes has been underway since late 2006, when an exclusivity payment was received.

Douglas Armstrong PhD, Chief Executive Officer of TyraTech said: "The global horticultural insecticide market includes fruits and vegetables as well as professional turf areas such as golf courses, where safer, more responsible insecticides are increasingly demanded by both the consumer as well as the regulatory agencies. TyraTech's technology is designed to meet this opportunity with active insecticides that have a strong combination of potency and safety, as well as providing a new solution to the increasing problem of insect resistance to traditional insecticides. With our partner Arysta, we can not only accelerate the development of products, but also have an experienced sales and marketing capability to bring these products into the commercial marketplace."

TyraTech is actively developing products for other markets that require safe and effective control of insects and invertebrate pathogens. In October TyraTech announced the release of its first TyraTech Naturals insecticide product, a general-use crawling insect spray for sale to businesses -- particularly the hospitality industry -- for direct insect control in inhabited spaces. Enabled by the safety profile of TyraTech Naturals, the Company is also working in close alliance with Kraft Foods to develop a line of functional food products intended for the prevention or control of intestinal parasites. The successful achievement of a major development milestone in this partnership was also recently announced by TyraTech.

Dr. Armstrong continued, "We are committed to establishing a new standard for commercial insecticides based on the unique level of combined potency and safety of TyraTech Naturals. Our recent progress is an exciting start for all involved from our hard working staff, our partners, our new customers, and particularly for our shareholders."

About TyraTech, Inc.

TyraTech is pioneering a new class of highly effective, non-toxic, pesticides and anti-parasitic compounds to address global agriculture, horticulture, functional foods, healthcare and veterinary markets. Using a revolutionary chemoreceptor screening process, TyraTech has identified proprietary blends of natural oils that stimulate the reactions and biological behavior of insects and parasites so that they can be effectively repelled or killed. TyraTech's technology inhibits the development of resistance and avoids the environmental concerns and human health risks of chemical solutions whilst still being at least, if not more, effective.

The Company's products have been validated through strong partnerships with multinational conglomerates operating within a growing US$23 billion worldwide market that is being increasingly driven by environmental legislation and end-user demand.

TyraTech continues to develop new product applications based on safe, natural ingredients with a broad range of partners around the world. http://www.tyratech.com

Press Contact:

Casey Cronin

Antenna Group (for TyraTech)

415-977-1912

casey@antennagroup.com


'/>"/>
SOURCE TyraTech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform
2. Kaiser Permanente Achieves Climate Action Leader Status
3. OSF HealthCare Achieves Impressive Tobacco Quit Rates with the Free & Clear(R) Quit For Life(TM) Program
4. LMS integrated obstetrics solution achieves general availability
5. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
6. Pharsight Achieves $7.3 Million in Quarterly Revenue
7. Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue
8. Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia
9. Joint Commission International Achieves Accreditation from ISQua
10. Free distribution of insecticide-treated mosquito nets can save lives
11. Kenyan malaria success strengthens call for free insecticide-treated nets for all
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... NuevaCare, a leading home ... as Millbrae, Belmont, and Palo Alto, is proud to announce an important upgrade to ... consumers look for home care close to home, and by having city-specific pages, NuevaCare ...
(Date:2/26/2017)... ... , ... ODH, Inc.™ announced today it will exhibit and speak at ... Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present ... population health management. , ODH will also have an exhibit booth where attendees may ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... TaskMate Go. Core benefits and advantages built into the home office sit stand ... look and feel. Ability to gain the benefits embedded in the TaskMate Go ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of genetic variants implicated ... to eight genes that may explain why susceptibility to one of the disorders could ... study published today in the journal npj Schizophrenia. , “There is a wealth ...
(Date:2/24/2017)... ... ... With millions of Americans and people worldwide struggling with ... aware of our options and are empowered with strength and information throughout the ... newest edition of "Vision and Hearing" in USA Today, that will educate readers ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Australien, 24. Februar 2017 ITL ... Unternehmen des Gesundheitsbereiches, ist erfreut, für das zum ... dem entsprechenden Vorjahreszeitraum exzellente Ergebnisse vorlegen zu können. ... Aktualisierung zum Wachstum" finden Sie hier . ... Gewinn nach Steuern 2,12 Millionen USD (Dez. 2015: 1,04 Millionen USD; +104 %) ...
(Date:2/24/2017)... 2017  Directors from Pharma To Market Pty Ltd and Ador ... resulting in the founding of Pharma To Market Pte Ltd, based ... are pleased to announce their expansion into Asia ... . The company are delighted to appoint Joelle Chia ... Singapore based entity. Joelle brings with her an ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
Breaking Medicine Technology: